Mirodenafil-d7 Dihydrochloride
| Product Name |
Mirodenafil-d7 Dihydrochloride
|
| Product Code |
DA-K004-q
|
| Chemical name |
Mirodenafil-d7 Dihydrochloride
|
| Synonyms |
5-Ethyl-3,5-dihydro-2-[5-[[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl]-2-(propoxy-d7)phenyl]-7-propyl-4H-pyrrolo[3,2-d]pyrimidin-4-one Hydrochloride; 4-[[3-(5-Ethyl-4,5-dihydro-4-oxo-7-propyl-1H-pyrrolo[3,2-d]pyrimidin-2-yl)-4-(propoxy-d7)phenyl]sulfonyl]-1-piperazineethanol Dihydrochloride; SK 3530-d7;
|
| Impurity |
NA
|
| CAS Number |
1329651-11-7
|
| Alternate CAS # |
NA
|
| Molecular form |
C26H32D7Cl2N5O5S
|
| Appearance |
NA
|
| Melting Point |
NA
|
| Mol. Weight |
611.63
|
| Storage |
2-8°C Refrigerator
|
| Solubility |
NA
|
| Stability |
NA
|
| Category |
aromatics,heterocycles,stable isotopes,pharmaceutical standards,intermediates,fine chemicals,sulphur and selenium compounds
|
| Boiling Point |
NA
|
| Applications |
Labelled Mirodenafil. A phosphodiesterase 5 inhibitor reported to be effective in the treatment of erectile dysfunction, is metabolized by cytochrome P 450 (CYP) 3A4 to the active metabolite N-dehydroxyethyl mirodenafil. Mirodenafil may have drug-drug interactions with ketoconazole and/or rifampicin.
|
| Dangerous Goods Info |
NA
|
| References |
NA
|
| Extra Notes |
NA
|
| Documents (MSDS) |
No Data Available
|
| Keywords |
NA |
